Back to Search
PEDRAM HAMRAH, M.D.
M.D.
Ophthalmology Physician
NPI: 1366483778IndividualAccepts Medicare
Education
OTHER
Class of 1999
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED
NCT02120079COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
NCT01250925COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection.
PMID 19623012·Transplantation·2009
7-preclinical
Herpes simplex keratitis and dendritic cells at the crossroads: lessons from the past and a view into the future.
PMID 19125064·Int Ophthalmol Clin·2009
6-review
Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.
PMID 19365012·Arch Ophthalmol·2009
3-trial
The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking.
PMID 17515886·Mol Vis·2007
7-preclinical
Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.
PMID 17325167·Invest Ophthalmol Vis Sci·2007
7-preclinical
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.
PMID 16849433·Proc Natl Acad Sci U S A·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 800 WASHINGTON ST
BOSTON, MA 02111 - Phone
- (617) 636-5000
Quick Facts
- NPI
- 1366483778
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 27
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile